The Death Of Disease Management (Finally)
- Only 2 of 15 programs resulted in reduced hospital admissions. None generated net savings.
- There were only 14 significant improvements in process-of-care measures out of 40 comparisons.
- These modest improvements came at substantial cost to the Medicare program in fees paid to the disease management companies ($400 million), with “no demonstrable savings in Medicare expenditures.”
Disease Management: RIP